NOPE for treatment of pathological muscle loss and weakness
US10799559B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 24, 2017 |
| Grant date | Oct 13, 2020 |
| Priority date | — |
| Expiry date | Apr 24, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating muscle wasting and other disorders with NOPE extracellular domain (ECD) polypeptides and NOPE ECD fusion molecules are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.